← Browse by Condition
Medical Condition

primary mediastinal diffuse large b cell lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06742502 Phase 2
Recruiting

Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL

Enrollment
30 pts
Location
China
Sponsor
Sun Yat-sen University
View Trial →